A Pathophysiological Study of the Postprandial Human Liver (PLS)
Key facts
- Who runs it
- Copenhagen University Hospital, Hvidovre
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 87 people enrolled
- Started
- 2 Mar 2019
- Ended
- 1 Sept 2025
- Type of study
- Interventional, 3 groups
- Treatments tested
- Standardised meal
- Glucagon bolus
- Record updated
- 6 July 2026
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- NAFLD (WP2, WP6):
- Cirrhosis (WP 3):
- T2DM and NAFLD (WP7):
Other criteria
- Healthy participants (WP1 , WP4 , WP5 ):
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Fatty liver disease is a globally widespread disease. The identification of valid biomarkers and targets for potential treatments requires in-depth knowledge about the pathophysiology of the postprandial liver. The study will consist of seven work packages (WP) including blood tests and liver biopsies taken after fasting or ingestion of a standardized meal in: healthy controls (WP 1), patients with NAFLD (WP 2), and patients with cirrhosis (WP 3) ; before and after a standardised meal in healthy controls (WP 4), and before and after glucagon in healthy controls (WP5), patients with NAFLD (WP6), and patients with T2DM and NAFLD (WP7).
The 3 groups in the trial
- Blood tests and liver biopsies after fasting or ingestion of a standardized mealTreatment being tested
Participants randomized to the meal group consume, over a period of five minutes, a standardized liquid meal (Nutridrink Standard, 200 mL, 300 kcal, Nutricia). Participants randomized to the fasting group remain fasted for one hour after arrival. A transjugular liver biopsy is then performed at minute 60. Blood samples are obtained throughout the study day.
Treatment: Standardised meal
- Blood tests and liver biopsies before and after a standardized mealTreatment being tested
A transjugular liver biopsy is performed, followed by ingestion of a standardized liquid meal (Nutridrink Standard, 200 mL, 300 kcal, Nutricia; 16% protein, 49% carbohydrate, 35% fat). A second transjugular liver biopsy is then performed 30 minutes after meal ingestion. Blood samples are obtained throughout the study day.
Treatment: Standardised meal
- Blood tests and liver biopsies before and after a bolus of glucagonTreatment being tested
A transjugular liver biopsy is performed, followed by an intravenous bolus of 0.2 mg glucagon. A second transjugular liver biopsy is then performed 30 minutes after meal ingestion. Blood samples are obtained throughout the study day.
Treatment: Glucagon bolus
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 6 July 2026